Pablo Garcia-Pavia
@dr_pavia
Followers
2K
Following
839
Media
138
Statuses
799
Head. HF & Inherited Cardiac Diseases. Hospital Puerta de Hierro. Group leader @ CNIC. Madrid, Spain. Associate Editor Rev Esp Cardiol.
Comunidad de Madrid, España
Joined March 2019
RT @Biotech_Spain: .@CNIC_CARDIO Genes linked to sudden cardiac death increase the risk of heart failure in patients with genetic dilated….
0
7
0
RT @CNIC_CARDIO: Sudden cardiac death genes increase heart failure risk in patients with dilated cardiomyopathy, study finds @dr_pavia @fer….
medicalxpress.com
A Spanish study shows that patients with genetic dilated cardiomyopathy who experience severe arrhythmias are at an elevated risk of developing advanced heart failure and requiring a heart transplant.
0
3
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
522
941
4K
RT @CNIC_CARDIO: 💡 A Spanish study published lead Pablo García-Pavía @dr_pavia and Fernando Domínguez @fernidom published in @ehj_ed and….
0
5
0
RT @drbennisahmed: Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. Among patients with symptomatic obstruc….
0
8
0
RT @MSBBrandao: @dr_pavia presents the results at 12 months of HELIOS-B open label extension study, with positive results that highlight th….
0
1
0
RT @CardiologyToday: At 24 weeks, compared with metoprolol, aficamten:. ❤️ improved peak oxygen uptake.❤️ improved quality of life and #hea….
healio.com
In patients with obstructive hypertrophic cardiomyopathy, the cardiac myosin inhibitor aficamten was superior to the beta-blocker metoprolol for improving symptoms and peak oxygen uptake, according...
0
1
0
RT @almucastro01: Pablo García-Pavía ( @dr_pavia) .presenta #MAPLEHCM.Excelentes resultados para aficamten frente a metoprolol en MHO.#ESC2….
0
4
0
RT @MSBBrandao: #ESCCongress #HOTLINE 2.MAPLE-HCM w/ impressive results presented by @dr_pavia .Are we headed to CMI as 1st line therapy fo….
0
11
0
RT @CFarmaceutico: #ESCCongress 🫀| Un estudio liderado por @dr_pavia, del Hospital Puerta de Hierro y @CNIC_CARDIO, cambia el paradigma de….
diariomedico.com
Una investigación internacional liderada por el cardiólogo español Pablo García-Pavía muestra la superioridad de un nuevo fármaco respecto al abordaje habitual de esta cardiopatía.
0
6
0
RT @fernidom: 🚨!! Just out in #EHJ and presented by @NereMA at #ESCCongress in Madrid.@escardio @ESC_Journals
0
22
0
RT @jpocardio: 🌍 HCM genetics is a continuum, not just rare Mendelian variants. (IEVs) are a missing piece of the puzzle. 💬 Should IEVs be….
0
8
0
RT @CNIC_CARDIO: 📣 #CNICatESCCongress El @dr_pavia, de @CNIC_CARDIO y Hospital Puerta de Hierro, repasa en @linternacope algunas de las nov….
cope.es
Pablo García Pavía, jefe de la Unidad de Cardiopatías Familiares, explica en La Linterna junto al divulgador científico Jorge Alcalde los últimos adelantos en las investigaciones en torno a este...
0
2
0
RT @MSBBrandao: Madrid 🇪🇦 is getting ready to host the royal ball of Cardiology 🫀.1️⃣ week until delegates from all over 🌎 get to be inspir….
0
9
0
It's been an honor and a pride to have you with us during this time Nerea! Hard work always pays off, and you're a great example! Stay tunned! 🤩🤩! We're sure you'll do great in Pamplona. You will always be part of the @cardiopdh family 🤗🤗.
After 3 years, I’ve completed my fellowship and my time as a Consultant Cardiologist at the Inherited Cardiac Conditions Unit at Puerta de Hierro! Grateful as I close this meaningful chapter, feeling both joy for what’s been and a hint of sadness for what I’m leaving behind.
0
1
20
RT @JuanSanchisFor: A robust framework for interpreting TTNtv beyond its traditional classification by sarcomeric bands, in dilated cardiom….
0
4
0
RT @InstitutoRoche: 🫀No te pierdas la entrevista con el @dr_pavia @CNIC_CARDIO @cardiopdh sobre el valor de la Medicina Personalizada de….
institutoroche.es
Trabajamos para traer al presente la Medicina del Futuro
0
2
0
ESC Congress LBT announced today! Delighted to present the results of the MAPLE-HCM trial in my hometown of MADRID! 🎉👏🏻🥳.Aficamten vs BB in monotherapy for obstructive HCM 🤔.Saturday 30th in Hot line session 2! .Stay tunned!! ⏱️.@CNIC_CARDIO @cardiopdh @Cytokinetics
5
24
77
RT @RevEspCardiol: 🔊 Revista Española de Cardiología strengthens its position among leading cardiovascular journals. 📊 #REC achieves an imp….
0
19
0
Gracias @evacorada por dar visibilidad al trabajo de investigación que hacemos en @CNIC_CARDIO y @cardiopdh .Mucho progreso durante estos años para los pacientes con amiloidosis pero esperemos que menos que lo que viviremos en el futuro!.
🔬 Amiloidosis trastiretina: así es cómo la investigación transforma una enfermedad rara. ✍ @evacorada.
1
1
7